普美显在肝硬化结节多步癌变及肝细胞癌早期诊断中的应用

丁莺; 曾蒙苏

doi:10.3969/j.issn.1001-5256.2013.10.004

普美显在肝硬化结节多步癌变及肝细胞癌早期诊断中的应用

DOI: 10.3969/j.issn.1001-5256.2013.10.004

丁莺,
曾蒙苏

1. 复旦大学附属中山医院放射科
2. 复旦大学上海医学院影像学系,上海市影像医学研究所

详细信息

中图分类号: R735.7
计量
- 文章访问数: 5917
- HTML全文浏览量: 19
- PDF下载量: 881
- 被引次数: 0
出版历程
- 收稿日期: 2013-06-21
- 出版日期: 2013-10-20

Clinical application of liver- specific contrast agent Gd+- EOB- DTPA in progression assessment and early diagnosis of hepatocellular carcinoma

Department of Radiology, Zhongshan Hospital, Fudan University

摘要

摘要: 普美显是一种肝细胞特异性对比剂,同时具有细胞内及细胞外功能,能被具有正常功能的肝细胞所摄取并排泄入胆道,其比例约为50%。回顾及总结了近2年来在本院放射科所做的普美显增强磁共振检查病例,重点研究了该对比剂对于早期或小肝细胞癌的检出、肝细胞癌分级的潜能及肝细胞癌多步癌变中肝硬化结节良恶性的鉴别这三方面,从而得出普美显对于肝细胞癌诊断的有效性及其独特优势,为临床肝细胞癌患者提供更为全面的信息。
- 普美显 /
- 磁共振成像 /
- 癌,肝细胞
Abstract: Gd+- EOB- DTPA, a liver- specific contrast agent for magnetic resonance imaging ( MRI) , has intracellular and extracellular functions. The contrast agent can be absorbed into normal liver cells and excreted into the bile, with an absorption rate of about 50% and an excretion rate of about 50%. The author reviews and summarizes the cases who underwent Gd+- EOB- DTPA- enhanced MRI in the Department of Radiology, Zhongshan Hospital in recent two years and focuses on the use of this contrast agent in following aspects: detection of early or small hepatocellular carcinoma ( HCC) , potential value for HCC grading, and differentiation between benign and malignant cirrhotic nodules in the multi- step progression of HCC. This review shows the effectiveness and unique advantage of Gd+- EOB- DTPA in the diagnosis of HCC, providing more comprehensive information for HCC patients.
- Gd+-EOB-DTPA /
- magnetic resonance imaging /
- carcinoma, hepatocellular

HTML全文

参考文献(13)

[1]SCHUHMANN-GIAMPIERI G, SCHMITT-WILLICH H, PRESS WR, et al.Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system[J].Radiology, 1992, 183 (1) :59-64.

[2]LINAG L, CHEN CZ, RAO SX, et al.Study of clinical application of hepatic-biliary specific MR contrast agent (Gd-EOB-DTPA) in the diagnosis of focal lesions[J].Radiol Practice, 2012, 27 (7) :765-770. (in Chinese) 梁亮, 陈财忠, 饶圣祥, 等.肝胆特异性磁共振对比剂GdEOB-DTPA在肝脏局灶性病变诊断中的应用研究[J].放射学实践, 2012, 27 (7) :765-770.

[3]SEUNG HK, WOO KJ, YONGSOO K, et al.Hepatocellular carcinoma composed of two different histologic types:imaging features on gadoxetic acid-enhanced liver MRI[J].Clin Mol Hepatol, 2013, 19 (1) :92-96.

[4]CHOL JW, LEE JM, KIM SJ, et al.Hepatocellular carcinoma:imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker[J].Radiology, 2013, 267 (3) :776-786.

[5]RAMAN SS, LEARY C, BLUEMKE DA, et al.Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging:a multicenter phase 3 clinical trial[J].J Comput Assist Tomogr, 2010, 34 (2) :163-172.

[6]ICHIKAWA T, SATIO K, YOSHIOKA N, et al.Detection and characterization of focal liver lesions:a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease[J].Invest Radiol, 2010, 45 (3) :133-141.

[7]SUN HY, LEE JM, SHIN CI, et al.Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (<2 cm in diameter) from arterial enhancing pseudolesions[J].Invest Radiol, 2010, 45 (2) :96-103.

[8]KIM HY, CHOI JY, KIM CW, et al.Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis[J].Liver Transpl, 2012, 18 (7) :850-857.

[9]Marin D, Brancatelli G, Federle MP, et al.Focal nodular hyperplasia:typical and atypical MRI findings with emphasis on the use of contrast media[J].Clin Radiol, 2008, 63 (5) :577-585.

[10]KITAO A, MATSUI O, YONEDA N, et al.The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis:correlation with gadoxetic acid enhanced MR imaging[J].Eur Radiol, 2011, 21 (10) :2056-2066.

[11]KANKI A, TAMADA T, HIGAKI A, et al.Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging:correlation with morphological grading of severity in cirrhosis and chronic hepatitis[J].Magn Reson Imaging, 2012, 30 (3) :356-360.

[12]International Working Party.Terminology of nodular hepatocellular lesions[J].Hepatology, 1995, 22 (3) :983-993.

[13]TAMADA T, ITO K, UEKI A, et al.Peripheral low intensity sign in hepatic hemangioma:diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver[J].J Magn Reson Imaging, 2012, 35 (4) :852-858.

施引文献

资源附件(0)

访问统计